CIPROFLOXACIN LACTATE

Ciprofloxacin Lactate (CAS 97867-33-9) combines ciprofloxacin with lactic acid to enhance solubility and bioavailability for intravenous use, and is traded to ChP and Ph.Int. standards in pharmaceutical grade by Ningbo Pangs Chem Co., Ltd, a non-manufacturing supplier. It is used to treat respiratory, urinary tract, skin and soft tissue, intra-abdominal, and bone and joint infections caused by susceptible Gram-negative and Gram-positive organisms, and is approved by regulatory agencies including the FDA and EMA. Samples are available, and it is distributed across North America, Europe, Australasia, Asia, the Middle East, and Africa.